Literature DB >> 27380572

Microvascular Decompression for Idiopathic Primary Trigeminal Neuralgia in Patients Over 75 Years of Age.

Hua Zhao1, Yinda Tang, Xin Zhang, Shiting Li.   

Abstract

OBJECTIVE: In the present study, the authors appraised the results of microvascular decompression in patients over 75 years of age.
METHODS: From June 2009 to June 2013, a number of 108 aged patients with primary trigeminal neuralgia experienced microvascular decompression. The authors present a retrospective review of medical records and compared the results with those of a control group of 302 younger patients.
RESULTS: The mean follow-up period was 3 years. No statistically marked differences were observed between the 2 groups in terms of rate of pain control, recurrences, complications. The duration of operation in the elderly group was markedly shorter than that in the younger group.
CONCLUSION: Microvascular decompression is a liable and safe surgical method for aged patients with primary trigeminal neuralgia. Unless the aged patients cannot bear general anesthesia, they should have the chance to select microvascular decompression.

Entities:  

Mesh:

Year:  2016        PMID: 27380572     DOI: 10.1097/SCS.0000000000002787

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  After microvascular decompression to treat trigeminal neuralgia, both immediate pain relief and recurrence rates are higher in patients with arterial compression than with venous compression.

Authors:  Lei Shi; Xiaoyan Gu; Guan Sun; Jun Guo; Xin Lin; Shuguang Zhang; Chunfa Qian
Journal:  Oncotarget       Date:  2017-07-04

Review 2.  Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures.

Authors:  Carolina Venda Nova; Joanna M Zakrzewska; Sarah R Baker; Richeal Ni Riordain
Journal:  World Neurosurg X       Date:  2020-01-27

3.  An age-dependent outcome analysis of microvascular decompression and percutaneous thermocoagulation in trigeminal neuralgia.

Authors:  Naureen Keric; Darius Kalasauskas; Sophia L Kreth; Martin B Glaser; Harald Krenzlin; Sven R Kantelhardt; Florian Ringel
Journal:  BMC Neurol       Date:  2021-04-29       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.